GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like <b>oneservice AG</b>, Announces The Appointment Of <b>Stephen L. Elliott</b> As President <b>Oneservice Inc. North America</b> July 31, 2017 What a Gilead-Incyte Marriage Would Look Like March 13, 2017 BioAmber Announces Year End Operational And Financial Results For 2016 March 16, 2017
<b>oneservice AG</b>, Announces The Appointment Of <b>Stephen L. Elliott</b> As President <b>Oneservice Inc. North America</b> July 31, 2017
